Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy.
Cancers (Basel). 2022 May 1;14(9):2266. doi: 10.3390/cancers14092266.
Cancers (Basel). 2022.
PMID: 35565395
Free PMC article.
Review.